Novel renin inhibiting peptides
US5071837A · kind A · utility
35Cited by
5References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 28, 1990 |
| Grant date | Dec 10, 1991 |
| Priority date | — |
| Expiry date | Nov 28, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns certain orally active novel renin-inhibitory peptides which are useful for treating renin-associated hypertension, congestive heart failure, hyperaldosteronism, and glaucoma. It is also useful for treating diseases caused by retroviruses including HTLV-I, -II, and -III. Process for preparing the peptides, compositions containing them, and methods of using them are included. Also included is a diagnostic method which uses the compounds to determine the presence of renin-associated hypertension, congestive heart failure, or hyperaldosteronism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.